AlphaCentric Advisors »

BioCryst Pharmaceuticals shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.4M 675k 5.08
2023-09-30 $4.6M 649k 7.08
2023-06-30 $4.0M 570k 7.04
2023-03-31 $3.5M 420k 8.34
2022-12-31 $1.4M 125k 11.48
2022-09-30 $882k 70k 12.60
2021-12-31 $242k 18k 13.83